Question Bank › Mid-ramp quarter: contribution has started but t

Mid-ramp quarter: contribution has started but the period only caught part of it

Calls Tested
421
Answered YES
20
Hit Rate
4.8%
rare by design

Cue Biopharma, Inc. (CUE) — this company's answers

NO on the Q3 2022 call 2022-11-14 D
The model's full reasoning — Q3 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了一个已经部分贡献的新业务活动,并明确表示报告期只捕获了部分早期阶段,而更完整的运行率将在未来几个季度到来,这是时间问题而非赢得问题。 检查三个条件: (1) 可命名的、已经上线或即将上线的新贡献者。管理层是否识别了最近开始或即将开始的具体业务?例如,CUE-102的临床试验已经开始,第一位患者已接受治疗。在电话会议中,Matteo说:“I'm also happy to report that we have treated our first patient with CUE-102, which targets Wilms tumor 1 positive tumors in the trial that is enrolling patients with advanced colorectal, gastric, pancreatic and ovarian cancers.” 这表示CUE-102试验已经开始,第一位患者已治疗。这是一个新的贡献者,已经上线。 (2) 报告期只捕获了部分,管理层明确表示。管理层是否表示报告结果只包含该贡献者正常水平的一小部分?对于CUE-102,它刚刚开始,第一位患者刚治疗,所以报告期(第三季度)可能只包含极少或没有数据。但管理层没有明确说报告期只捕获了部分,因为CUE-102是刚刚开始,可能还没有数据。然而,管理层提到CUE-102的剂量递增试验正在进行,数据将在2023年中期报告。但报告期是2022年第三季度,CUE-102可能刚启动,所以报告期可能没有贡献。但管理层没有明确说“报告期只捕获了部分”,而是说“我们很高兴报告我们已经治疗了第一位患者”,这暗示刚刚开始。但条件(2)要求管理层明确表示报告期只包含部分,因为开始于期中或仍在爬坡。这里管理层没有明确说报告期只包含部分,但可以推断。然而,我们需要严格根据管理层的话。管理层说“The trial is actively accruing and will be open at 15 sites around the United States. We plan to present additional data at an upcoming medical meeting.” 这表示试验正在积极招募,但未提及报告期只包含部分。可能不满足。 (3) 更完整的贡献是时间问题而非赢得问题。管理层是否将路径描述为执行问题,如爬坡速度、时间表?对于CUE-102,管理层说“We plan to present additional data at an upcoming medical meeting.” 但没有明确说更完整的贡献是时间问题。此外,CUE-102是新的临床试验,其贡献是未来的数据,而不是收入。但问题问的是“new business activity”,可能指临床试验的进展,但临床试验不是收入来源。然而,公司是生物技术公司,其业务是开发药物,临床试验的进展是核心。但问题要求“contributing”可能指收入或业务活动。这里CUE-102是新的临床试验,已经开始,但报告期可能没有数据。但管理层没有明确说报告期只捕获了部分。 另外,还有CUE-101的扩展队列,但那是已有的。还有融资,但那是融资。 检查其他部分:管理层提到“With CUE-101 monotherapy expansion cohort... will have mature median overall survival data by the end of this year” 但那是未来的数据,不是已经开始的贡献。 关键点:CUE-102是新的,但管理层没有明确说报告期只捕获了部分,也没有说更完整的贡献是时间问题。他们只是说第一位患者已治疗,试验正在进行,数据将在未来报告。这更像是计划中的进展,而不是已经部分贡献的业务。 此外,问题要求“identifiable piece of new business activity that has ALREADY STARTED CONTRIBUTING PARTWAY THROUGH THE REPORTED PERIOD OR IS STARTING RIGHT NOW” 并且“make clear that the reported results captured only a PARTIAL, EARLY SLICE of it”。管理层没有明确说报告期只捕获了部分。他们只是说第一位患者已治疗,但报告期是第三季度,可能CUE-102在第三季度末或第四季度开始,所以报告期可能没有贡献。但管理层没有说“报告期只包含部分”,而是说“我们很高兴报告我们已经治疗了第一位患者”,这暗示刚刚开始,但未明确说报告期只包含部分。 另外,还有CUE-101的扩展队列,但那是已有的。 因此,我认为不满足条件(2)和(3)。管理层没有明确说报告期只捕获了部分,也没有说更完整的贡献是时间问题。他们只是说试验正在进行,数据将在未来报告。 所以答案应为NO。

← Back to the full CUE analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe an identifiable piece of new business activity that has ALREADY STARTED CONTRIBUTING PARTWAY THROUGH THE REPORTED PERIOD OR IS STARTING RIGHT NOW — and make clear that the reported results captured only a PARTIAL, EARLY SLICE of it, with the fuller run-rate arriving over the next few quarters as a matter of timing rather than as a matter of winning anything further? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent timing story with all three of the following present: (1) A NAMEABLE NEW CONTRIBUTOR THAT IS ALREADY LIVE OR JUST GOING LIVE. Management identifies specific business that recently began or is beginning now — for example, a contract or program whose deliveries or billings recently started; a facility, location, line, or capacity that recently opened or is opening; a product, service, or offering that recently launched and is now selling; a customer or group of customers recently onboarded and now ramping; an acquisition recently closed and now contributing; or newly added capability now taking on its first real volume. The contributor must be described as actually transacting or commencing — real revenue, orders, shipments, output, or activity happening — not as pipeline, negotiation, or plan. (2) THE REPORTED PERIOD CAUGHT ONLY PART OF IT, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the just-reported results include only a fraction of this contributor's normal level — because it started mid-period, is still ramping toward its intended level, or its costs arrived ahead of its revenue — so the printed numbers understate the level the business is already operating at or stepping to. (3) THE FULLER CONTRIBUTION IS A TIMING MATTER, NOT A WINNING MATTER. Management discusses the path to the fuller level in execution terms — ramp pace, onboarding, production schedules, utilization building, quarters until full contribution — with the remaining uncertainty being how fast, not whether the business exists. Management should treat this arriving contribution as meaningful to the company's trajectory, not as a minor housekeeping item. Answer NO if the new activity is only planned, signed-but-not-started, contingent on approvals or financing, or still pipeline. NO if the contributor is already fully reflected in results with no meaningful further phase-in ahead. NO if the forward story rests mainly on market recovery, demand strength, or hoped-for wins rather than on the phase-in of activity already begun. NO if the ramp described is routine, immaterial, or the company's ordinary ongoing cadence that management does not treat as changing its level of business. NO if management is chiefly explaining delays, shortfalls, or problems with a previously promised ramp. NO if the timing story appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GPRE Green Plains Inc. Q4 2023 2024-02-07 F
TEL TE Connectivity Ltd. Q4 2023 2023-11-01 B
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
MAS Masco Corporation Q3 2018 2018-10-30 C
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
HTLF Heartland Financial USA, Inc. Q3 2017 2017-10-30 B+
MXL MaxLinear, Inc. Q2 2017 2017-08-08 C+
FLEX Flex Ltd. Q1 2018 2017-07-28 F
LEA Lear Corporation Q2 2017 2017-07-26 B+
DAN Dana Incorporated Q1 2017 2017-05-02 B
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C
PDCO Patterson Companies, Inc. Q3 2017 2017-02-23 C
WTS Watts Water Technologies, Inc. Q4 2016 2017-02-10 B

How the model reasoned

SHOO · Q1 2017 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes the Schwartz & Benjamin acquisition as a new contributor that began delivering sales in the reported Q1 period ($14 million, slightly above plan), with the results capturing only its early partial slice. Management explicitly notes that the full-quarter impact will arrive in subsequent quarters (dragging gross margin more going forward), 2017 will be breakeven-to-EPS, and meaningful profit contribution starts in 2018—making the fuller run-rate a pure timing matter of integration and ramp rather than any further winning. This meets all three criteria. (Madden NYC and SM Europe are also new launches/JVs with early/modest contributions and growth ahead, but Schwartz & Benjamin is the clearest fit for the exact timing story.) NO for the other items because they are either not yet live (China JV), not described as partial/early-slice (SM Europe international growth), or not framed as timing-driven ramp (Madden NYC modest contribution is positive but 2018+ profit is more about execution than pure timing). The answer is YES.
AFL · Q2 2023 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes the WINGS cancer insurance product launch in Japan Post (early April, during Q2) as a new, nameable contributor that began transacting mid-period. Management explicitly states it was the "majority contributor" to the 60% cancer sales increase in Q2 versus 2022, 26.6% overall sales premium growth, and notes the reported results captured only an early slice because "right when you launch the product, you'll have an immediate jump in sales in the early months followed by a calming down" with "still much more runway...
PDCO · Q3 2017 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes Heartland Dental as a new customer relationship that began contributing in January (during the reported Q3 period), with the rollout completed on schedule and the business now "getting close to being fully operational." Management explicitly notes that this was "not a significant contributor to consumable sales in the third quarter" — confirming the reported results captured only a partial, early slice — while highlighting the "outstanding start" and excitement for further growth as the relationship scales.

More from the question bank

Ecosystem forming: independent outsiders areOperating without a netCall runs ahead of the accountsCustomers eating the frictionBuying its own future outputBetting the balance sheet on one live opportAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.